Important News

Back to Index

Prior Review Updates - effective 3/01/2012


Criteria for coverage of Growth Hormones (somatropin) will include use of Omnitrope prior to all other growth hormones on the market

Change in Prior Review for Growth Hormones for ALL users

Coverage for Disease Modifying Drugs for MS: interferon beta (Extavia, Avonex ) will be updated. Betaseron will be preferred over Extavia and Rebif will be preferred over Avonex for NEW users

Change in Prior Review for Disease Modifying Drugs for Multiple Sclerosis (MS) interferon beta (Extavia®, Avonex®) for NEW users

Tesamorelin will require prior review/certification for ALL users

Prior Review Required for tesamorelin (Egrifta®) for ALL users

BCBSNC is changing the administrative process regarding coverage of Renin Inhibitors for NEW users

Prior Review Required for Renin Inhibitors for NEW users